BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 30674393)

  • 1. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
    Lai SY; Johnson FM
    Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the interleukin-6/Jak/stat pathway in human malignancies.
    Sansone P; Bromberg J
    J Clin Oncol; 2012 Mar; 30(9):1005-14. PubMed ID: 22355058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases.
    Zalpoor H; Nabi-Afjadi M; Forghaniesfidvajani R; Tavakol C; Farahighasreaboonasr F; Pakizeh F; Dana VG; Seif F
    Cell Mol Biol Lett; 2022 Jul; 27(1):60. PubMed ID: 35883021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
    Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
    Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
    Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
    Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
    Durham GA; Williams JJL; Nasim MT; Palmer TM
    Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
    Coskun M; Salem M; Pedersen J; Nielsen OH
    Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis.
    Trivedi S; Starz-Gaiano M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression.
    Mohrherr J; Haber M; Breitenecker K; Aigner P; Moritsch S; Voronin V; Eferl R; Moriggl R; Stoiber D; Győrffy B; Brcic L; László V; Döme B; Moldvay J; Dezső K; Bilban M; Popper H; Moll HP; Casanova E
    Int J Cancer; 2019 Dec; 145(12):3376-3388. PubMed ID: 31407334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
    Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
    Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway.
    Vafadari R; Weimar W; Baan CC
    Clin Chim Acta; 2012 Sep; 413(17-18):1398-405. PubMed ID: 22261016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
    Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
    Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies.
    Mughal TI; Girnius S; Rosen ST; Kumar S; Wiestner A; Abdel-Wahab O; Kiladjian JJ; Wilson WH; Van Etten RA
    Leuk Lymphoma; 2014 Sep; 55(9):1968-79. PubMed ID: 24206094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
    Ferrajoli A; Faderl S; Ravandi F; Estrov Z
    Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
    Manea SA; Manea A; Heltianu C
    Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK/STAT pathway modulation: Does it work in dermatology?
    Gündüz Ö
    Dermatol Ther; 2019 May; 32(3):e12903. PubMed ID: 30964573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
    Groner B; von Manstein V
    Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining for JAK-STAT mutations in cancer.
    Constantinescu SN; Girardot M; Pecquet C
    Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.